Literature DB >> 9147289

Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.

A Nicot1, W B Rowe, E R De Kloet, C Betancur, D S Jessop, S L Lightman, R Quirion, W Rostène, A Bérod.   

Abstract

Adrenocorticotropin (ACTH) secretion depends primarily on hypophysiotrophic factors released from neurons of the paraventricular nucleus of the hypothalamus. However, the neurochemical factors controlling these neurons, in particular neuropeptides, have had little investigation. In this study, we have investigated the role of neurotensin in the regulation of the different components of the hypothalamo-pituitary-adrenal (HPA) axis under basal and stress conditions in rats. For this purpose, animals were implanted with bilateral cannulae filled with crystals of the neurotensin antagonist, SR 48692, and which were located above the paraventricular nucleus. Five days after surgery, the effects of SR 48692 implants were studied on basal and stress-induced secretion of ACTH and corticosterone. Such treatment did not modify plasma levels of ACTH and corticosterone in basal conditions but reduced ACTH but not corticosterone levels after tail cut procedure. After an exposure to a novel environment for 30 min, both ACTH and corticosterone plasma levels were reduced in the SR 48692-treated group. In situ hybridization studies revealed that chronic administration of SR 48692 induced a significant reduction of CRF mRNA levels in the parvocellular division of the paraventricular nucleus of the hypothalamus. In addition, a 2-fold increase in basal levels of plasma vasopressin associated with an increase in vasopressin mRNA levels in the magnocellular neurons of the paraventricular nucleus was also detected. Finally, the basal plasma levels of oxytocin were not affected by the same treatment. Taken together, these findings strongly suggest that endogenous neurotensin in the paraventricular nucleus plays a tonic stimulatory role on HPA axis activity and an inhibitory effect on vasopressin secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9147289     DOI: 10.1046/j.1365-2826.1997.00581.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  10 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

Review 2.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine.

Authors:  C Betancur; R Cabrera; E R de Kloet; D Pélaprat; W Rostène
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

Review 4.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

Review 5.  In Search of Concomitant Alterations of Dopaminergic and Neurotensinergic Systems in Stress Conditions.

Authors:  Georgina Rodríguez de Lores Arnaiz; Marta C Antonelli
Journal:  Neurochem Res       Date:  2016-02-11       Impact factor: 3.996

6.  Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.

Authors:  Siobhan Briody; Mona Boules; Alfredo Oliveros; Irfan Fauq; Elliott Richelson
Journal:  Behav Brain Res       Date:  2009-10-02       Impact factor: 3.332

7.  Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice.

Authors:  Terri M Driessen; Changjiu Zhao; Anna Whittlinger; Horecia Williams; Stephen C Gammie
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome.

Authors:  Magdalini Vasiadi; Jennifer Newman; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2014-10-31       Impact factor: 8.322

Review 9.  New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.

Authors:  Ilaria Barchetta; Marco Giorgio Baroni; Olle Melander; Maria Gisella Cavallo
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 6.208

10.  Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity.

Authors:  Zherui Wu; Nicolas Stadler; Amazigh Abbaci; Jin Liu; Agnès Boullier; Nicolas Marie; Olivier Biondi; Marthe Moldes; Romain Morichon; Bruno Feve; Olle Melander; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-08       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.